SCHEMBL17972739

SCHEMBL17972739

COCCOCCOCCN(CCNC(=O)OCc1ccccc1)CCNC(=O)OCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
L3MBTL1 Q9Y468 3/20 0.50
HTT P42858 1/20 0.50
MAPT P10636 1/20 0.49
TGM2 P21980 1/20 0.45
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
SLC1A3 P43003 1/20 0.43
SLC1A1 P43005 1/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
FOLH1 Q04609 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KAT2B Q92831 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13531477 0.94 SMN1; SMN2 (0.71) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL21338331 0.93 LMNA (0.55) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL11990340 0.92 SMN1; SMN2 (0.73) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL40348 0.92 SMN1; SMN2 (0.63) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL18594580 0.87 SMN1; SMN2 (0.83) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL11990353 0.86 LMNA (0.64) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL17972790 0.85 SMN1; SMN2 (0.63) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL14288938 0.85 LMNA (0.69) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL11990357 0.84 SMN1; SMN2 (0.64) LMNASMN1; SMN2L3MBTL1HTTMAPT
SCHEMBL8389256 0.82 SMN1; SMN2 (0.74) LMNASMN1; SMN2L3MBTL1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160221971-A1 DI-MACROCYCLES LUMIPHORE, INC. (US) 2016-08-04 US disclosed
US-20160221971-A1 DI-MACROCYCLES LUMIPHORE, INC. (US) 2016-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221971-A1 DI-MACROCYCLES DLD, NDC1, MCL1 LMNA 3243/4885SMN1; SMN2 3304/4885L3MBTL1 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.